Institut National de la Sante et de la Recherche Medicale
Posted: 30 September 2026 - Crcm, France
This position involves working in the team of Jean-Paul Borg/Flavio Maina at the CRCM, focusing on developing CAR-T cells against tumor antigens. The role requires expertise in immunotherapy, molecular biology, and preclinical research techniques. The candidate will evaluate CAR-T cell efficacy and generate new CAR constructs for testing.